Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aim Immunotech Inc (AIM)

Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,196
  • Shares Outstanding, K 3,276
  • Annual Sales, $ 170 K
  • Annual Income, $ -17,320 K
  • EBIT $ -15 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.26
  • Price/Sales 7.97
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -19.00
  • Most Recent Earnings $-0.32 on 11/17/25
  • Next Earnings Date 03/26/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.94
  • Number of Estimates 1
  • High Estimate -0.94
  • Low Estimate -0.94
  • Prior Year -10.00
  • Growth Rate Est. (year over year) +90.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7653 +10.24%
on 02/09/26
1.8799 -55.12%
on 02/05/26
-0.4463 (-34.60%)
since 01/09/26
3-Month
0.7653 +10.24%
on 02/09/26
1.8799 -55.12%
on 02/05/26
-0.7313 (-46.43%)
since 11/11/25
52-Week
0.7653 +10.24%
on 02/09/26
36.0000 -97.66%
on 04/07/25
-14.1963 (-94.39%)
since 02/11/25

Most Recent Stories

More News
AIM ImmunoTech Announces Commencement of Rights Offering

OCALA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...

AIM : 0.8437 (-13.51%)
accesso® and Adyen Expand Strategic Partnership to Enhance Platform Payments Capabilities at Global Scale

ORLANDO, Fla. , Feb. 10, 2026 /CNW/ --  accesso Technology Group  (AIM: ACSO), the premier technology solutions provider to leisure, entertainment, and cultural markets,...

AIM : 0.8437 (-13.51%)
accesso® and Adyen Expand Strategic Partnership to Enhance Platform Payments Capabilities at Global Scale

ORLANDO, Fla. , Feb. 10, 2026 /PRNewswire/ --  accesso Technology Group  (AIM: ACSO), the premier technology solutions provider to leisure, entertainment, and cultural markets,...

AIM : 0.8437 (-13.51%)
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026

Register for the two-day virtual event here

AKTX : 0.2456 (+1.45%)
AIM : 0.8437 (-13.51%)
DCOY : 0.7260 (-2.95%)
BULL : 6.24 (-6.02%)
GRI : 2.39 (unch)
MBRX : 4.18 (+0.97%)
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

Live video webcast on Wednesday, February 11 th at 1:40 PM EST OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM)  (“AIM” or the “Company”),...

AIM : 0.8437 (-13.51%)
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

OCALA, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM)  (“AIM” or the “Company”) today reported positive data in a year-end update from the ongoing Phase...

AIM : 0.8437 (-13.51%)
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering

OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) –  AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...

AIM : 0.8437 (-13.51%)
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering

OCALA, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...

AIM : 0.8437 (-13.51%)
accesso® Expands Venue-Controlled Resale Capability

Partnership with menta tech gives venues verified, white-label resale while keeping control of pricing, data and guest relationships.

AIM : 0.8437 (-13.51%)
AIM ImmunoTech Announces Stock Dividend

OCALA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) --   AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every...

AIM : 0.8437 (-13.51%)

Business Summary

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM...

See More

Key Turning Points

3rd Resistance Point 1.0954
2nd Resistance Point 1.0280
1st Resistance Point 0.9358
Last Price 0.8437
1st Support Level 0.7762
2nd Support Level 0.7088
3rd Support Level 0.6166

See More

52-Week High 36.0000
Fibonacci 61.8% 22.5403
Fibonacci 50% 18.3827
Fibonacci 38.2% 14.2250
Last Price 0.8437
52-Week Low 0.7653

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar